Hoth Therapeutics, Inc.(NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing therapies for serious and underserved conditions, today announced it has achieved a major European ...
With May the Fourth waiting in the (Starfighter) wings, do keep your eyes peeled for all the new Star Wars releases at Disney Store — after all, to quote our favorite green Jedi Grand Master, when it ...
(RTTNews) - Hoth Therapeutics (HOTH) announced its collaboration with OnTargetx R&D to advance research for its cancer-fighting therapeutic, HT-KIT. The study focuses on: development and optimization ...
Hoth Therapeutics (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies for underserved ...
Development and optimization of staining methods for (c-Kit) markers, a critical target in HT-KIT therapeutic mechanism. Processing and qualitative evaluation of tissue samples by a board-certified ...
Hoth Therapeutics filed two provisional patent applications with the U.S. Patent and Trademark Office, expanding the company’s intellectual property portfolio along with establishing a new ...
NEW YORK, Feb. 10, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback